Division of Pediatric Critical Care, Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pediatric Biochemistry Unit, Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
J Trop Pediatr. 2021 Jan 29;67(1). doi: 10.1093/tropej/fmaa107.
Mitochondrial dysfunction is central to sepsis-induced multi-organ dysfunction. Thiamine deficiency may contribute to mitochondrial dysfunction and thus high mortality. Study was planned to assess thiamine status in children with septic shock in comparison to healthy controls from a developing country and to study the effect of thiamine levels on its outcome.
A prospective case-control study (April 2017 to May 2018) enrolling consecutive children with septic shock as 'cases' (n = 76), their healthy siblings (n = 51) and apparently healthy children from immunization clinic (n = 35) as 'controls'. Whole blood total thiamine (WBTT) level was measured on days 1, 10 and 1-month post-discharge. Outcome parameters were acute care area free days on days 14 and 28, and mortality.
WBTT [nMol/l; median (interquartile range, IQR)] was significantly lower on day 1 in cases compared with sibling controls [23.1 (21.8-26.3) vs. 36.9 (33.6-40.5); p < 0.001]. It fell further on day 10 [20.8 (18.1-21.1); p < 0.02]. Levels rose significantly 1-month post-discharge [35.5 (31.2-36.6)] and became comparable to sibling controls (p = 0.4). Immunization clinic controls also had lower WBTT [42.3 (40.1-45.9)], but was significantly higher than sibling controls and cases at 1-month post-discharge (p < 0.001). Survivors and non-survivors of septic shock were similar. WBTT levels did not correlate with any of the severity indicators of septic shock or its outcomes.
WBTT was significantly low in all children, and fell further during septic shock. Observed severe deficiency might have precluded any further association of thiamine levels with severity of septic shock and its outcome. Data obtained may inform trials on metabolic resuscitation in paediatric septic shock in developing countries. Lay summaryThiamine deficiency may contribute to high mortality in paediatric septic shock as thiamine is an essential factor for functioning of mitochondria, the powerhouse of the cells. This prospective case-control study was conducted to assess thiamine status in children with septic shock in comparison with healthy controls in a developing country. Consecutive children with fluid-refractory septic shock were enrolled as 'cases'. Their apparently healthy siblings, and apparently healthy children from immunization clinic, were enrolled as 'controls'. The whole blood total thiamine (WBTT) level was measured on days 1, 10 and 1 month after hospital discharge. Seventy-six children were enrolled as cases, 51 children as sibling controls and 35 children as immunization clinic controls. WBTT was significantly lower on day 1 in cases as compared with their sibling controls. It fell further on day 10. The level rose significantly after a month of discharge and became comparable to sibling controls. Immunization clinic controls also had lower WBTT but was significantly higher compared with sibling controls and cases at 1-month post-discharge. Survivors and non-survivors of septic shock had similar WBTT levels. Observed severe deficiency might have precluded any further association of thiamine levels with septic shock outcome.
线粒体功能障碍是脓毒症引起多器官功能障碍的核心。硫胺素缺乏可能导致线粒体功能障碍,从而导致高死亡率。本研究旨在评估来自发展中国家的脓毒性休克患儿的硫胺素状况,并研究其水平对预后的影响。
一项前瞻性病例对照研究(2017 年 4 月至 2018 年 5 月)纳入了连续的脓毒性休克患儿作为“病例”(n=76),其健康兄弟姐妹(n=51)和免疫接种诊所的健康儿童作为“对照”(n=35)。在出院后第 1、10 和 1 天测量全血总硫胺素(WBTT)水平。预后参数为第 14 和 28 天急性护理区无天数和死亡率。
与兄弟姐妹对照组相比,病例组第 1 天的 WBTT [nMol/l;中位数(四分位距,IQR)]显著降低[23.1(21.8-26.3)vs. 36.9(33.6-40.5);p<0.001]。第 10 天进一步下降[20.8(18.1-21.1);p<0.02]。出院后 1 个月,水平显著升高[35.5(31.2-36.6)],并与兄弟姐妹对照组相当(p=0.4)。免疫接种诊所对照组的 WBTT [42.3(40.1-45.9)]也较低,但与兄弟姐妹对照组和病例组在出院后 1 个月时相比明显更高(p<0.001)。脓毒性休克幸存者和非幸存者的 WBTT 水平相似。WBTT 水平与脓毒性休克的任何严重指标或其结果均无相关性。
所有儿童的 WBTT 均显著降低,在脓毒性休克期间进一步降低。观察到的严重缺乏可能使硫胺素水平与脓毒性休克严重程度及其预后之间的任何进一步关联都变得不可能。获得的数据可能为发展中国家儿童脓毒性休克代谢复苏的试验提供信息。
硫胺素缺乏可能导致儿科脓毒性休克的高死亡率,因为硫胺素是线粒体功能的必需因素,线粒体是细胞的能量工厂。本前瞻性病例对照研究旨在评估来自发展中国家的脓毒性休克患儿的硫胺素状况与健康对照组相比。连续纳入液体难治性脓毒性休克患儿作为“病例”。将其健康的兄弟姐妹和免疫接种诊所的健康儿童纳入“对照组”。在第 1、10 和出院后 1 天测量全血总硫胺素(WBTT)水平。共纳入 76 例患儿为病例,51 例患儿为兄弟姐妹对照,35 例患儿为免疫接种诊所对照。与兄弟姐妹对照组相比,病例组第 1 天的 WBTT 显著降低。第 10 天进一步下降。出院后 1 个月,水平显著升高,与兄弟姐妹对照组相当。免疫接种诊所对照组的 WBTT 也较低,但与兄弟姐妹对照组和病例组在出院后 1 个月时相比明显更高。脓毒性休克幸存者和非幸存者的 WBTT 水平相似。观察到的严重缺乏可能使硫胺素水平与脓毒性休克结局之间的任何进一步关联都变得不可能。